skip navigation

Skip Nav

Clinical Guidelines Portal

skip navigation

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Syphilis

(Last updated:5/7/2013; last reviewed:5/7/2013)

Syphilis
Member Financial Disclosure
Company Relationship
Bolan, Gail
Centers for Disease Control and Prevention None N/A
Ghanem, Khalil
Johns Hopkins University
Becton-Dickenson
Consultant, Honoraria
Hook, Edward W. 
University of Alabama at Birmingham
Becton-Dickenson
Honoraria, Research Support
Gen Probe
Research Support
GlaxoSmithKline
Research Support
Merck Honoraria
Siemens Research Support
Stoner, Brad
Washington University School of Medicine
None N/A
Wendel, George
University of Texas Southwestern
None N/A
Workowski, Kim*
Emory University
CDC Other
Gliead Consultant
Merck Consultant
Tibotec Research Support
Vertex Research Support
*Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.